0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Journal Articles

in Neurocutaneous Diseases

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Dermatology
Editorial  | 
Efficacy of Rapamycin in Tuberous Sclerosis–Associated Hypopigmented Macules: Back to the Future
Jack L. Arbiser, MD, PhD
JAMA Dermatology
Original Investigation  | 
Clinical and Histologic Analysis of the Efficacy of Topical Rapamycin Therapy Against Hypomelanotic Macules in Tuberous Sclerosis Complex
Mari Wataya-Kaneda, MD, PhD; Mari Tanaka, MD, PhD; Lingli Yang, MD, PhD; et al.
JAMA Ophthalmology
Research Letter  | 
Massive Retinal Gliosis in Neurofibromatosis Type 1
Frederick A. Jakobiec, MD, DSc; Alia Rashid, MBChB; Kyle Lewis, MD
JAMA Surgery
JAMA Surgery Clinical Challenge  | 
Bleeding Abdominal Mass in a Patient With Genetic Cutaneous Disorder
Shawn S. Fu, MD; Jeffrey A. McDavit, MD; Ilia Gur, MD